Literature DB >> 16158526

Immunologic work-up study for inner ear disorders: looking for a rational strategy.

José Ramón García-Berrocal1, Almudena Trinidad, Rafael Ramírez-Camacho, David Lobo, María Verdaguer, Andrés Ibáñez.   

Abstract

CONCLUSIONS: For the evaluation of a patient with suspected immune-mediated inner ear disease (IMIED), an exhaustive immunologic work-up study is not recommended if financial resources are limited. Analysis of antinuclear antibodies (ANA) and the immunophenotype of peripheral blood lymphocytes (PBL) proved to be the most useful tests in our population to support the clinical diagnosis of IMIED.
OBJECTIVE: Owing to the lack of specific serological markers for the diagnosis of IMIED, an exhaustive immunologic work-up study for patients with suspected IMIED is usually performed. The aim of this study was to estimate the use of resources and the costs involved in the routine laboratory tests used for the diagnosis of IMIED.
MATERIAL AND METHODS: This was a comparative study of two groups of patients with a high suspicion of diverse clinical forms of IMIED who were subjected to different serologic test designs. The cost of the classical immunologic work-up study used for the diagnosis of IMIED (n=125) was estimated in comparison with that of a more restricted examination, based on a recently reported high-risk profile, involving the analysis of ANA and PBL (n=57).
RESULTS: The diagnostic efficiency of the two protocols was similar. The cost of a complete immunologic work-up study was 241.77 euros and that of the limited analysis was 53.12 euros.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16158526     DOI: 10.1080/00016480510038059

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  9 in total

1.  Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach.

Authors:  José Ramón García-Berrocal; Andrés Ibáñez; Antonio Rodríguez; José Angel González-García; José María Verdaguer; Almudena Trinidad; Rafael Ramírez-Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-27       Impact factor: 2.503

Review 2.  New prospects in the diagnosis and treatment of immune-mediated inner ear disease.

Authors:  David R Lobo; Jose Ramon García-Berrocal; Rafael Ramírez-Camacho
Journal:  World J Methodol       Date:  2014-06-26

Review 3.  A comprehensive study of oxidative stress in sudden hearing loss.

Authors:  Fatih Gul; Togay Muderris; Gokhan Yalciner; Ergun Sevil; Sami Bercin; Merve Ergin; Mehmet Ali Babademez; Muzaffer Kiris
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-10       Impact factor: 2.503

4.  TNFalpha blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis.

Authors:  David Lobo; Almudena Trinidad; José Ramón García-Berrocal; Jose María Verdaguer; Rafael Ramírez-Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-18       Impact factor: 2.503

5.  Investigation of the prognostic role of neutrophil-to-lymphocyte ratio in Idiopathic Sudden Sensorineural Hearing Loss based on propensity score matching: a retrospective observational study.

Authors:  Shiyuan Wu; Zaizai Cao; Fangling Shi; Bobei Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-13       Impact factor: 2.503

Review 6.  The diagnosis of autoimmune inner ear disease: evidence and critical pitfalls.

Authors:  Roberto Bovo; Andrea Ciorba; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-06       Impact factor: 2.503

7.  Combination Immunosuppressive Therapy in Primary Autoimmune Inner Ear Disease in Pregnancy.

Authors:  Saikrishna Ananthapadmanabhan; Joe Jabbour; David Brown; Vanaja Sivapathasingam
Journal:  Case Rep Otolaryngol       Date:  2022-03-18

Review 8.  Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment.

Authors:  Laura Girasoli; Diego Cazzador; Roberto Padoan; Ennio Nardello; Mara Felicetti; Elisabetta Zanoletti; Franco Schiavon; Roberto Bovo
Journal:  J Immunol Res       Date:  2018-09-26       Impact factor: 4.818

9.  Autoimmune Vestibulopathy-A Case Series.

Authors:  Surangi Mendis; Nicola Longley; Simon Morley; George Korres; Diego Kaski
Journal:  Brain Sci       Date:  2022-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.